Want to see SXTP full AI Analyst Report?
60 Degrees Pharmaceuticals, Inc. (SXTP) Ratios
60 Degrees Pharmaceuticals, Inc. Ratios
SXTP's free cash flow for Q2 2026 was $-2.23M. For the 2026 fiscal year, SXTP's free cash flow was increased by $0.00 and operating cash flow was $-2.23M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.66 | 3.25 | 2.55 | 0.05 | 1.85 |
| Quick Ratio | 2.30 | 2.98 | 2.39 | 0.02 | 0.77 |
| Cash Ratio | 0.82 | 1.00 | 0.76 | 0.01 | 0.18 |
| Solvency Ratio | -3.67 | -4.37 | -1.23 | -0.24 | -0.21 |
| Operating Cash Flow Ratio | -3.72 | -3.41 | -1.60 | -0.04 | -1.02 |
| Short-Term Operating Cash Flow Coverage | -780.78 | -643.88 | -517.89 | -0.05 | -6.91 |
| Net Current Asset Value | $ 2.91M | $ 3.58M | $ 4.26M | $ -24.35M | $ -18.37M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.02 | 17.28 | 13.49 |
| Debt-to-Equity Ratio | 0.04 | 0.04 | 0.04 | -0.95 | -1.07 |
| Debt-to-Capital Ratio | 0.04 | 0.04 | 0.03 | -19.35 | 15.33 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.04 | 0.03 | -0.06 | 16.07 |
| Financial Leverage Ratio | 1.55 | 1.43 | 1.60 | -0.06 | -0.08 |
| Debt Service Coverage Ratio | -439.02 | -472.55 | -0.62 | -0.08 | -0.31 |
| Interest Coverage Ratio | -994.05 | -1227.87 | -2.25 | -0.44 | -0.35 |
| Debt to Market Cap | 0.11 | 0.05 | 0.00 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.24 | 1.44 | 2.48 | 18.27 | 15.20 |
| Net Debt to EBITDA | 0.19 | 0.19 | 1.38 | -10.50 | -18.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.26% | 36.67% | -87.15% | -93.71% | 26.68% |
| EBIT Margin | -732.05% | -1308.07% | -602.16% | -980.22% | -93.64% |
| EBITDA Margin | -723.80% | -1297.58% | -562.58% | -944.92% | -87.46% |
| Operating Profit Margin | -771.64% | -1598.97% | -2032.78% | -784.22% | -96.88% |
| Pretax Profit Margin | -732.82% | -1309.37% | -1503.93% | -2767.50% | -367.07% |
| Net Profit Margin | -732.82% | -1308.01% | -1485.06% | -2769.49% | -366.42% |
| Continuous Operations Profit Margin | -732.82% | -1309.41% | -1504.02% | -2767.73% | -367.16% |
| Net Income Per EBT | 100.00% | 99.90% | 98.75% | 100.07% | 99.82% |
| EBT Per EBIT | 94.97% | 81.89% | 73.98% | 352.90% | 378.91% |
| Return on Assets (ROA) | -137.31% | -137.99% | -48.38% | -476.54% | -305.11% |
| Return on Equity (ROE) | -212.76% | -196.93% | -77.32% | 26.22% | 24.19% |
| Return on Capital Employed (ROCE) | -220.20% | -236.83% | -104.17% | 7.74% | -148.29% |
| Return on Invested Capital (ROIC) | -219.65% | -236.32% | -103.70% | 118.61% | -125.08% |
| Return on Tangible Assets | -143.30% | -141.86% | -49.83% | -545.63% | -331.06% |
| Earnings Yield | -541.58% | -271.04% | -1.55% | -0.38% | -0.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.97 | 1.25 | 1.10 | 4.86 | 7.93 |
| Payables Turnover | 0.54 | 0.38 | 0.94 | 0.57 | 1.45 |
| Inventory Turnover | 1.19 | 0.87 | 1.02 | 0.83 | 1.23 |
| Fixed Asset Turnover | 4.08 | 4.06 | 3.56 | 6.58 | 10.78 |
| Asset Turnover | 0.19 | 0.11 | 0.03 | 0.17 | 0.83 |
| Working Capital Turnover Ratio | 0.30 | 0.15 | -0.03 | -0.02 | 1.50 |
| Cash Conversion Cycle | -189.64 | -243.42 | 302.19 | -127.52 | 89.10 |
| Days of Sales Outstanding | 185.01 | 292.41 | 332.99 | 75.16 | 46.04 |
| Days of Inventory Outstanding | 306.74 | 420.02 | 358.55 | 437.78 | 295.62 |
| Days of Payables Outstanding | 681.39 | 955.86 | 389.35 | 640.46 | 252.56 |
| Operating Cycle | 491.75 | 712.43 | 691.54 | 512.94 | 341.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -10.22 | -49.70 | -4.59 | -0.70 | -0.45 |
| Free Cash Flow Per Share | -10.54 | -51.29 | -4.71 | -0.74 | -0.47 |
| Dividend Paid and CapEx Coverage Ratio | -31.41 | -31.19 | -39.20 | -16.80 | -18.34 |
| Capital Expenditure Coverage Ratio | -31.41 | -31.19 | -39.20 | -16.80 | -18.34 |
| Operating Cash Flow Coverage Ratio | -44.83 | -36.23 | -26.31 | -0.05 | -0.03 |
| Operating Cash Flow to Sales Ratio | -6.81 | -9.30 | -17.92 | -4.52 | -0.56 |
| Free Cash Flow Yield | -519.44% | -198.81% | -1.92% | -0.07% | -0.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -0.35 | -64.36 | -262.63 | -381.85 |
| Price-to-Sales (P/S) Ratio | 1.35 | 4.83 | 955.82 | 7273.61 | 1399.18 |
| Price-to-Book (P/B) Ratio | 0.39 | 0.73 | 49.77 | -68.86 | -92.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.19 | -0.50 | -52.02 | -1517.15 | -2371.85 |
| Price-to-Operating Cash Flow Ratio | -0.20 | -0.52 | -53.35 | -1607.48 | -2501.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 5.74 | -5.89 | -9.03 |
| Enterprise Value Multiple | -0.00 | -0.18 | -168.52 | -780.26 | -1618.26 |
| Enterprise Value | 3.24K | 1.43M | 240.40M | 1.65B | 1.64B |
| EV to EBITDA | -0.00 | -0.18 | -168.52 | -780.26 | -1618.26 |
| EV to Sales | 0.00 | 2.35 | 948.05 | 7372.86 | 1415.29 |
| EV to Free Cash Flow | -0.00 | -0.25 | -51.60 | -1537.86 | -2399.15 |
| EV to Operating Cash Flow | -0.00 | -0.25 | -52.92 | -1629.42 | -2529.97 |
| Tangible Book Value Per Share | 4.71 | 33.42 | 4.62 | -16.82 | -12.64 |
| Shareholders’ Equity Per Share | 5.17 | 35.51 | 4.92 | -16.31 | -12.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 1.50 | 5.35 | 0.26 | 0.15 | 0.80 |
| Net Income Per Share | -10.99 | -69.93 | -3.80 | -4.28 | -2.94 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 2.50 | 2.82 | 3.92 |
| Research & Development to Revenue | 2.09 | 8.21 | 2.73 | 2.35 | 4.75 |
| SG&A to Revenue | 6.25 | 8.27 | 16.73 | 5.84 | 0.96 |
| Stock-Based Compensation to Revenue | 0.45 | 5.94 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.93 | 0.71 | 1.21 | 0.16 | 0.15 |
Currency in USD
